FORM 8.1(a) & (b) (Opening Position Disclosure)
DUBLIN, Nov. 5, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS):
IRISH TAKEOVER PANEL
OPENING POSITION DISCLOSURE UNDER RULE 8.1(a) AND (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR OR AN OFFEREE
1. KEY INFORMATION
(a)
Full name of discloser:
Alkermes plc
(b)
Owner or controller of interests and short
positions disclosed, if different from 1(a):
The naming of nominee or vehicle
companies is insufficient. For a trust, the
trustee(s), settlor and beneficiaries must
be named.
N/A
(c)
Name of offeror/offeree in relation to whose
relevant securities this form relates:
Use a separate form for each offeror/offeree
Avadel
Pharmaceuticals
plc
(d)
Is the discloser the offeror or the offeree?
OFFEROR
(e)
Date position held:
The latest practicable date prior to the
disclosure
3 November
2025
(f)
In addition to the company in 1(c) above, is
the discloser also making disclosures in
respect of any other party to the offer?
If it is a cash offer or possible cash offer, state
"N/A"
N/A
2. INTERESTS AND SHORT POSITIONS
If there are interests and positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.
Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates (Note 1)
N/A
All interests and all short positions should be disclosed.
Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.
3. INTERESTS AND SHORT POSITIONS OF PERSONS ACTING
IN CONCERT WITH THE PARTY MAKING THE DISCLOSURE
Details of any interests and short positions (including directors'
and other employee options) of any person acting in concert with
the party making the disclosure:
Interests of J.P. Morgan (together with its members of staff under Rule
3.3(b)(v) of Part A of the Irish Takeover Rules), financial advisors to
Alkermes plc, but, for clarity, not held on behalf of Alkermes plc:
Party
Class of
Relevant
Security
Number of
ordinary
shares held
at midnight
(ET) on
3 November
2025
Percentage
of total
issued share
capital
(rounded)
55I, LLC
Ordinary
shares of
US$0.01
each
53
0.0001 %
JPMorgan
Chase Bank,
National
Association
Ordinary
shares of
US$0.01
each
13,500
0.0139 %
TOTAL
13,553
0.0139 %
Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should
be given on a Supplemental Form 8.
Ap11
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement
or understanding, formal or informal, relating to relevant securities
which may be an inducement to deal or refrain from dealing entered
into by the party to the offer making the disclosure or any person
acting in concert with it:
Irrevocable commitments and letters of intent should not be included. If
there are no such agreements, arrangements or understandings, state
"none"
None
(b) Agreements, arrangements or understandings
relating to options or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred
to on this form or relating to the voting rights or future acquisition
or disposal of any relevant securities to which any derivative
referred to on this form is referenced. If none, this should be stated.
None
(c) Attachments
Is a Supplemental Form 8 attached?
YES/NO
No
Date of disclosure:
5 November 2025
Contact name:
Sandy Coombs, Alkermes
Telephone number:
+1 781 609 6377
Public disclosures under Rule 8.1 of the Rules must be made to a
Regulatory Information Service.
Ap12
NOTES ON FORM 8.1(a) and (b)
SOURCE Alkermes plc